Physician profile
Elena Jackson
NPI 1285850974
$1,613.99
in general payments reported to CMS, 2019-2025
13 companies · $38.70 in 2025
The $38.70 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $273 · 2021: $312 · 2022: $259 · 2023: $236 · 2024: $348 · 2025: $38.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $622.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $622.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $374.49 | 2019-2023 | Bexsero, Pediarix |
| Cranial Technologies, INC | $310.02 | 2019-2025 | Doc Band |
| Merck Sharp & Dohme LLC | $230.05 | 2019-2024 | Vaxelis, Vaxneuvance, Gardasil 9 |
| Sanofi Pasteur INC. | $165.36 | 2020-2025 | |
| Pfizer INC. | $153.19 | 2019-2024 | |
| Phadia US INC. | $123.65 | 2021-2024 | Immunocap |
| Sobi, INC | $56.39 | 2021-2023 | |
| Hologic Sales and Service, LLC | $44.14 | 2024 | Aptima, Thinprep 2000 Processor |
| Ucb, INC. | $42.63 | 2024 | Briviact |
| Alk-Abello, INC | $38.99 | 2023 | Ragwitek, Odactra, Grastek |
| Seqirus USA INC | $34.50 | 2023-2024 | Flucelvax Quadrivalent, Fluad, Flucelvax |
| Sanofi-Aventis U.S. LLC | $20.31 | 2023 | |
| Novartis Pharmaceuticals Corporation | $20.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elena Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.